Teleflex Incorporated (TFX) has been in the limelight for quite a variety of reasons over the past year. The shares have been subject to numerous sales and acquisitions by a range of investors, indicating shifting strategies and evaluations of TFX.
NorthCrest Asset Management buying a total of
2,497 shares is a prominent instance. Certain financial organizations, including
Robeco Institutional Asset Management B.V. and
Voya Investment Management LLC, have drastically sold their stakes in Teleflex. Additionally, there has been conflicting sentiment from market analysts about TFX, with average rating shifting between 'sell' and 'hold'. Notably,
Weiss ratings reaffirmed a 'sell' position, whereas
Zacks Research downgraded TFX to 'hold'. The company’s stocks also saw a fluctuation, occasionally outperforming or lagging when compared to the competitors, along with hitting a 52-week low. Significant company events include the
acquisition of BIOTRONIK's Vascular Intervention Business, launching of
Barrigel in Japan, and the plan to split into two publicly traded firms by 2026. Furthermore, the company showed mixed financials and had its earnings estimate lowered for '25. This factor possibly led to a degree of bearish sentiment and contributed to the stock's weak performance.
Teleflex Incorporated TFX News Analytics from Fri, 01 Nov 2024 07:00:00 GMT to Fri, 10 Oct 2025 21:29:00 GMT -
Rating -2
- Innovation -4
- Information 8
- Rumor -6
